NEW YORK, NY / ACCESSWIRE / March 17, 2017 / The Pawar Law Group announces a class action lawsuit on behalf of USANA Health Sciences (NYSE: USNA) investors who purchased USANA stock between March 14, 2014 and February 7, 2017, inclusive (the "Class Period"). The suit is for recovery of investor losses.

To participate in this class action lawsuit, visit the firm's website at http://pawarlawgroup.com/cases/usana-health-sciences/ or email Vik Pawar, Esq. at vik@pawarlawgroup.com or call toll free at (866) 999-0873.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the complaint, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) USANA's BabyCare subsidiary had engaged in improper reimbursement practices in China; (2) these practices constituted violations of the Foreign Corrupt Practices Act; (3) as such, USANA's China revenues were in part the product of unlawful conduct and unlikely to be sustainable; (4) the foregoing conduct, when it became known, was likely to subject USANA to significant regulatory scrutiny; and (5) as a result, USANA's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You may join the case here: http://pawarlawgroup.com/cases/usana-health-sciences/, or email Vik Pawar, Esq. at vik@pawarlawgroup.com.

Contact:

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (212) 571-0805
Fax: (212) 571-0938
vik@pawarlawgroup.com

SOURCE: Pawar Law Group